Lobbying disclosures · Lobbying report
TFX: second_quarter 2026 lobbying report
Issues related to physician reimbursement, prior authorization, breakthrough medical devices, and obesity treatments. Issues related to medical device tariffs.
Follow TFX- Became public
- Jul 20, 2026, 4:43 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 10, 2026, 1:49 PM EST
Why this is connected
Legal-name match: TELEFLEX INCORPORATED is TELEFLEX INC (https://www.sec.gov/Archives/edgar/data/96943/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).
Reported lobbying amounts
Income: $40,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/362a917a-8fa6-4c3f-9745-511f029d5371/","filing_uuid":"362a917a-8fa6-4c3f-9745-511f029d5371","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/362a917a-8fa6-4c3f-9745-511f029d5371/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Eugenia Edwards Pierson","dt_posted":"2026-07-20T16:43:55-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 Massachusetts Ave. NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":4301,"url":"https://lda.gov/api/v1/registrants/4301/","house_registrant_id":31381,"name":"ARNOLD & PORTER KAYE SCHOLER LLP","description":"Law firm","address_1":"601 Massachusetts Ave. NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NICHOLAS TOWNSEND","contact_telephone":"+1 202-942-5249","dt_updated":"2026-07-30T11:53:37.108571-04:00"},"client":{"id":53880,"url":"https://lda.gov/api/v1/clients/53880/","client_id":53880,"name":"TELEFLEX INCORPORATED","general_description":"Provider of medical technologies in the fields of urology and vascular access, among many.","client_government_entity":null,"client_self_select":false,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-11-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to physician reimbursement, prior authorization, breakthrough medical devices, and obesity treatments.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63646,"prefix":null,"prefix_display":null,"first_name":"EUGENIA","nickname":null,"middle_name":null,"last_name":"PIERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141902,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73516,"prefix":null,"prefix_display":null,"first_name":"CASEY","nickname":null,"middle_name":null,"last_name":"BROUHARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150529,"prefix":null,"prefix_display":null,"first_name":"CAROLINE","nickname":null,"middle_name":null,"last_name":"OLIVER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153193,"prefix":null,"prefix_display":null,"first_name":"AISHWARYA","nickname":null,"middle_name":null,"last_name":"GRANDHE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to medical device tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63646,"prefix":null,"prefix_display":null,"first_name":"EUGENIA","nickname":null,"middle_name":null,"last_name":"PIERSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141902,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73516,"prefix":null,"prefix_display":null,"first_name":"CASEY","nickname":null,"middle_name":null,"last_name":"BROUHARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150529,"prefix":null,"prefix_display":null,"first_name":"CAROLINE","nickname":null,"middle_name":null,"last_name":"OLIVER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153193,"prefix":null,"prefix_display":null,"first_name":"AISHWARYA","nickname":null,"middle_name":null,"last_name":"GRANDHE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in TFX
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Jul 22, 2025 · disclosed Aug 13, 2025 · Spouse
- Aug 13, 2025$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Jul 16, 2025 · disclosed Aug 13, 2025 · Spouse
- Mar 27, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Feb 25, 2025 · disclosed Mar 27, 2025
- Nov 8, 2023$1K–$15K
- Aug 13, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Jul 12, 2023 · disclosed Aug 13, 2023
- May 19, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
$15K–$50K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Dec 1, 2014$15K–$50K
Sen. Susan M. Collins (R-ME)
$15K–$50K · Traded Nov 10, 2014 · disclosed Dec 1, 2014 · Spouse
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.